apoQlar is excited to announce the successful close of a €10 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐀 funding round, marking a significant milestone in our journey. This round saw robust participation from YZR Capital, IFB Innovationsstarter GmbH and several business angels, demonstrating strong investor confidence in our vision and market potential. The new capital will accelerate our product development, expand distribution networks, and enhance regulatory and research capabilities to meet the growing global demand. This funding enables us to push the boundaries of medical technology and set new standards in patient care and medical training. With the support of our investors and our dedicated team across four continents, we are poised to make significant strides in the health-tech industry. We look forward to leveraging this investment to further establish our leadership and continue advancing healthcare outcomes through innovation. #startup #funding #medtech #healthcare #investment #SeriesA Dörte Bunge Markus Feuerecker
Thats great and awesome news. The founding Partners of Unicorn Anchor - Robert Skrobak and myself - are proud to push and support Sirko Pelzl and Marc-Angelo Bisotti and the ApoQlar Team in that Round and our unique matchmaking setup. All the best and road to become a #Unicorn!
Great work
Congratulations Sirko Pelzl and apoQlar team!
Principal bei IFB Innovationsstarter GmbH
5moI'm very pleased to be able to accompany apoQlar in our #innoventurefund in the future